Imelda Hospital
Bonheiden, 2820, Belgium
NCT Number: NCT04770597
Ventilation with fresh outdoor air has recently gained considerable attention as a means to reduce the potential risk of indoor aerosol transmission of respiratory pathogens such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease 2019 (COVID-19). Commercial carbon dioxide (CO2) monitors are increasingly used in schools, long-term care facilities, offices and public buildings to monitor indoor ventilation. However, no formal evidence is available to support the effectiveness of feedback from CO2 monitoring devices. Moreover, modern hospitals have superior indoor air quality control systems.
The aim of this prospective pilot randomized controlled trial (RCT) is to evaluate whether CO2 monitoring devices would be useful as a means to further maintain lower indoor CO2 concentrations in hospitals.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Bonheiden, 2820, Belgium
In this pilot, randomized, sham-controlled open-label RCT, hospital rooms will be fitted with Aranet4 Home CO2 sensors.
Each device will continuously measure indoor CO2 concentrations at 1-minute intervals during 4 time periods:
2-3. Sham/Intervention period: sensors on the same ward will be randomized to placebo (sensor not showing CO2 levels to staff) or Intervention (sensor displaying CO2 levels to staff) in a cross-over design
Each measurement period will consist of 7 days with no washout period.
Our primary hypothesis is that CO2 sensors will record less time (minutes) with elevated CO2 levels during the intervention period, compared to the Sham periods. However, carry-over effects will be investigated by comparing the Intervention periods to the Baseline and Post-intervention phases.
Note [February 27, 2021]: due to technical problems with the Aranet4 device Bluetooth connection, outcome data will be analyzed according to measurement data at 2-5 minute intervals (measurements can be made every minute, but data cannot be downloaded with the current version of the app due to technical problems).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The sensor is placed in the room at a height between 1 and 2 meters and not near the window or door.
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Time/day (in minutes/24h) measuring >800 ppm CO2
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Time/day (in minutes/24h) measuring >1000 ppm CO2
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Time/day (in minutes/24h) measuring >1400 ppm CO2
Time frame: 7 days/time period (pre-, active/sham and post-intervention)
Daily peak CO2 concentration [in ppm]
Time frame: 7 days
How feasible is it to use CO2 sensors to monitor indoor air quality in hospital? Anonymous online survey during the post-intervention phase
Time frame: 7 days
Would you prefer to use CO2 sensors to monitor indoor air quality in hospital in the future? Anonymous online survey during the post-intervention phase
Imelda Hospital, Bonheiden
Other
Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital: a Randomized, Sham-controlled, Open Label Trial
Acronym: MICH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04192435
Anesthesia, Bleeding
Melbourne, Victoria, Australia
View Trial DetailsNCT03924934
Bacterial Infections, Bacterial Infections and Mycoses
Chapel Hill, North Carolina, United States
View Trial DetailsNCT04579094
Cross Infection, Disease Attributes
Nîmes, France
View Trial DetailsNCT06216080
Central Venous Catheter Associated Bloodstream Infection, Critical Illness
Chalon-sur-Saône, Saône-et-Loire, France
View Trial Details